Advertisement
Screener

FULCRUM THERAPEUTICS, INC. (FULC) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

FULCRUM THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where FULCRUM THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $60.06M went out.
  • Fiscal year ended 2025-12-31: from investing, $30.72M came in.
  • Fiscal year ended 2025-12-31: from financing, $168.67M came in.
  • Fiscal year ended 2025-12-31: change in cash, $139.32M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$60.06M$30.72M$4.17M$164.50M*$139.32M
2024-12-31-$2.22M$32.23M$2.75M$32.76M
2023-12-31-$90.97M-$36.69M$777.00K$117.34M*-$9.54M
2022-12-31-$97.05M$12.41M$3.52M$80.80M*-$314.00K
2021-12-31-$78.48M-$129.67M$3.67M$182.84M*-$21.64M
2020-12-31-$53.66M-$57.14M$1.43M$69.70M*-$39.66M
2019-12-31-$39.48M-$944.00K$249.00K$64.09M*$23.92M
2018-12-31-$22.56M-$8.98M$12.00K$105.01M*$73.48M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$16.04M*$13.78M*$356.00K*
2026-03-31-$18.75M-$128.21M$21.00K-$147.27M
2025-12-31-$16.80M*-$1.05M*$3.80M*$164.50M*
2025-09-30-$14.19M*$18.61M*$64.00K*
2025-06-30-$13.82M*$13.93M*$301.00K*
2025-03-31-$15.26M-$777.00K$0.00-$16.03M
2024-12-31-$16.76M*$2.26M*$83.00K*
2024-09-30-$19.07M*$4.35M*$635.00K*
2024-06-30$58.90M*-$12.51M*$377.00K*
2024-03-31-$25.28M$38.13M$1.65M$14.49M
2023-12-31-$23.16M*$18.35M*$287.00K*
2023-09-30-$22.91M*$19.02M*$0.00*
2023-06-30-$20.79M*$19.88M*$142.00K*
2023-03-31-$24.12M-$93.94M$348.00K$117.34M*-$364.00K
2022-12-31-$19.70M*-$36.36M*$267.00K*
2022-09-30-$27.88M*-$2.28M*$93.00K*$80.85M*
2022-06-30-$27.37M*$31.39M*$2.81M*
2022-03-31-$22.11M$19.66M$348.00K-$2.10M
2021-12-31-$21.86M*-$9.09M*$969.00K*
2021-09-30-$22.57M*-$106.64M*$2.38M*$135.53M*
2021-06-30-$17.82M*-$26.35M*$231.00K*
2021-03-31-$16.23M$12.41M$93.00K$47.41M*$43.69M
2020-12-31-$19.83M*-$14.60M*$532.00K*$5.72M*
2020-09-30-$4.50M*$14.09M*$88.00K*
2020-06-30-$14.12M*-$226.00K*$523.00K*$64.16M*
2020-03-31-$15.20M-$56.40M$286.00K-$71.33M
2019-12-31-$4.50M*-$108.00K*$0.00*
2019-09-30-$13.02M*-$214.00K*$31.00K*$65.17M*
2019-06-30-$12.07M*-$221.00K*$220.00K*-$749.00K*
2019-03-31-$9.90M-$401.00K-$2.00K-$10.35M
2018-12-31-$6.40M*-$3.47M*-$6.00K*
2018-09-30-$4.12M*-$926.00K*$1.00K*$79.82M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02